Phase I trial of in situ vaccination with autologous CCL21 gene-modified dendritic cells (CCL21DC) combined with pembrolizumab for advanced non-small cell lung cancer (NSCLC)
CANCER RESEARCH(2022)
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要
CANCER RESEARCH(2022)